# Editorial: Mobilization of hematopoietic cells from the bone marrow to the peripheral blood: Challenges and new therapeutic targets

**Authors:** Agata Szade, Gunsagar S. Gulati, Agnieszka D. Czechowicz

PMC · DOI: 10.3389/fphar.2025.1592559 · 2025-04-22

## Full-text entities

- **Diseases:** severe combined immunodeficiency (MESH:D016511), hemoglobinopathies (MESH:D006453), neuroblastoma (MESH:D009447), BOS (MESH:D000092122), diseases (MESH:D004194), bone marrow disorders (MESH:D001855), blood and (MESH:D006402), GVHD (MESH:D006086), acute myeloid leukemia (MESH:D015470), cancer (MESH:D009369), myelofibrosis (MESH:D055728), hematologic malignancies (MESH:D019337)
- **Chemicals:** cyclophosphamide (MESH:D003520), tacrolimus (MESH:D016559), cladribine (MESH:D017338), forskolin (MESH:D005576), treprostinil (MESH:C427248), ROS (MESH:D017382), ruxolitinib (MESH:C540383), steroid (MESH:D013256), cinacalcet (MESH:D000069449), cytarabine (MESH:D003561), Busulfan (MESH:D002066), cobalt porphyrins (-), chrysin (MESH:C043561), purine (MESH:C030985)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12053172